HK1197602A1 - Unnatural reactive amino acid genetic code additions - Google Patents
Unnatural reactive amino acid genetic code additionsInfo
- Publication number
- HK1197602A1 HK1197602A1 HK14111287.3A HK14111287A HK1197602A1 HK 1197602 A1 HK1197602 A1 HK 1197602A1 HK 14111287 A HK14111287 A HK 14111287A HK 1197602 A1 HK1197602 A1 HK 1197602A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- amino acid
- genetic code
- reactive amino
- acid genetic
- code additions
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/41—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B11/00—Diaryl- or thriarylmethane dyes
- C09B11/04—Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
- C09B11/06—Hydroxy derivatives of triarylmethanes in which at least one OH group is bound to an aryl nucleus and their ethers or esters
- C09B11/08—Phthaleins; Phenolphthaleins; Fluorescein
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47993103P | 2003-06-18 | 2003-06-18 | |
US49301403P | 2003-08-05 | 2003-08-05 | |
US49654803P | 2003-08-19 | 2003-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1197602A1 true HK1197602A1 (en) | 2015-03-13 |
Family
ID=33568596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14111287.3A HK1197602A1 (en) | 2003-06-18 | 2014-11-07 | Unnatural reactive amino acid genetic code additions |
Country Status (10)
Country | Link |
---|---|
US (5) | US7993872B2 (es) |
EP (5) | EP1636340A4 (es) |
JP (4) | JP5275566B2 (es) |
CN (1) | CN102618605B (es) |
BR (1) | BRPI0411475A (es) |
CA (1) | CA2527877A1 (es) |
ES (1) | ES2773664T3 (es) |
HK (1) | HK1197602A1 (es) |
MX (1) | MXPA05013833A (es) |
WO (1) | WO2005003294A2 (es) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070166741A1 (en) | 1998-12-14 | 2007-07-19 | Somalogic, Incorporated | Multiplexed analyses of test samples |
JP2005502322A (ja) * | 2001-04-19 | 2005-01-27 | ザ スクリップス リサーチ インスティテュート | 非天然アミノ酸のインビボ組込み |
KR20050073559A (ko) | 2002-10-16 | 2005-07-14 | 더 스크립스 리서치 인스티튜트 | 당단백질 합성 |
US7618775B2 (en) * | 2003-04-17 | 2009-11-17 | The Scripps Research Institute | Expanding the eukaryotic genetic code |
EP1636340A4 (en) | 2003-06-18 | 2009-02-11 | Scripps Research Inst | COMPLEMENTS TO THE GENETIC CODE OF UNNATURATIVE REACTIVE AMINO ACIDS |
EP1658366A4 (en) | 2003-07-07 | 2006-08-09 | Scripps Research Inst | COMPOSITIONS OF ORTHOGONAL GLUTAMYL-TRNA AND AMINOACYL-TRNA-SYNTHETASEPAARES AND THEIR USES |
PT1914314E (pt) | 2003-07-07 | 2010-09-08 | Scripps Research Inst | Composições de pares ortogonais de lisil-arnt e aminoacil-arnt-sintetase e suas utilizações |
JP5657850B2 (ja) | 2003-10-14 | 2015-01-21 | ザ スクリプス リサーチ インスティテュート | 酸化還元機能性アミノ酸のタンパク質への部位特異的組み入れ |
MXPA06008496A (es) | 2004-02-02 | 2007-01-30 | Ambrx Inc | Polipeptidos de interferon humano modificados y sus usos. |
BRPI0511482A (pt) * | 2004-05-25 | 2007-12-26 | Scripps Research Inst | incorporação sìtio-especìfica de aminoácidos artificiais contendo átomos pesados em proteìnas para determinação de estrutura cristalina |
MXPA06014684A (es) * | 2004-06-18 | 2007-02-12 | Ambrx Inc | Novedosos polipeptidos de enlace antigeno y sus usos. |
US7718410B2 (en) * | 2004-09-21 | 2010-05-18 | The Scripps Research Institute | In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
WO2006036779A2 (en) * | 2004-09-22 | 2006-04-06 | The Scripps Research Institute | Site-specific labeling of proteins for nmr studies |
BRPI0517381A (pt) | 2004-10-27 | 2008-10-07 | Scripps Research Inst | componentes ortogonais de tradução para a incorporação in vivo de aminoácidos não naturais |
BRPI0518661A2 (pt) * | 2004-12-22 | 2008-12-02 | Ambrx Inc | mÉtodos para expressço e purificaÇço do hormânio do crescimento humano recombinante |
GB0428012D0 (en) * | 2004-12-22 | 2005-01-26 | Hammersmith Imanet Ltd | Radiolabelling methods |
KR101224781B1 (ko) | 2004-12-22 | 2013-01-21 | 암브룩스, 인코포레이티드 | 비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물 |
MX2007007580A (es) * | 2004-12-22 | 2007-12-11 | Ambrx Inc | Hormona del crecimiento humana modificada. |
GB0507123D0 (en) * | 2005-04-08 | 2005-05-11 | Isis Innovation | Method |
KR20080069993A (ko) * | 2005-10-12 | 2008-07-29 | 더 스크립스 리서치 인스티튜트 | 파지-디스플레이된 폴리펩티드의 선별적인 번역후 변형 |
US20100247433A1 (en) * | 2005-10-14 | 2010-09-30 | California Institute Of Technology | Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells |
HUE025489T2 (en) * | 2006-01-17 | 2016-04-28 | Somalogic Inc | Multiplexed analysis of test samples |
KR20080108416A (ko) * | 2006-01-19 | 2008-12-15 | 암브룩스, 인코포레이티드 | 조절된 면역원성을 갖는 비천연 아미노산 폴리펩티드 |
US7776535B2 (en) * | 2006-02-06 | 2010-08-17 | Franklin And Marshall College | Site-specific incorporation of fluorinated amino acids into proteins |
JP5589186B2 (ja) * | 2006-03-09 | 2014-09-17 | ザ スクリプス リサーチ インスティテュート | 真正細菌宿主細胞における直交翻訳成分の発現システム |
US8217145B2 (en) | 2006-03-16 | 2012-07-10 | The Scrips Research Institute | Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
US7632492B2 (en) * | 2006-05-02 | 2009-12-15 | Allozyne, Inc. | Modified human interferon-β polypeptides |
US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
WO2007139870A1 (en) * | 2006-05-23 | 2007-12-06 | The Scripps Research Institute | Genetically encoded fluorescent coumarin amino acids |
JP2009541286A (ja) * | 2006-06-21 | 2009-11-26 | ハマースミス・イメイネット・リミテッド | 化学的方法及び装置 |
US8420792B2 (en) * | 2006-09-08 | 2013-04-16 | Ambrx, Inc. | Suppressor tRNA transcription in vertebrate cells |
AU2012203737B2 (en) * | 2006-09-08 | 2014-06-19 | Ambrx, Inc. | Modified human plasma polypeptide or Fc scaffolds and their uses |
CN101511866A (zh) * | 2006-09-08 | 2009-08-19 | Ambrx公司 | 经修饰的人类血浆多肽或Fc骨架和其用途 |
AU2013202770B2 (en) * | 2006-09-08 | 2015-08-20 | Ambrx, Inc. | Modified human plasma polypeptide or Fc scaffolds and their uses |
CN106008699A (zh) * | 2006-09-08 | 2016-10-12 | Ambrx公司 | 经修饰的人类血浆多肽或Fc骨架和其用途 |
KR20090057072A (ko) * | 2006-09-08 | 2009-06-03 | 암브룩스, 인코포레이티드 | 척추동물 세포에 의한 비천연 아미노산의 부위 특이적 도입 |
CA2662753C (en) * | 2006-09-08 | 2016-02-23 | Ambrx, Inc. | Hybrid suppressor trna for vertebrate cells |
MX2009002987A (es) * | 2006-09-21 | 2009-04-28 | Scripps Research Inst | Expresion geneticamente programada de proteinas selectivamente sulfatadas en eubacterias. |
JP2010506591A (ja) * | 2006-10-18 | 2010-03-04 | ザ スクリップス リサーチ インスティテュート | 哺乳動物細胞中の蛋白質への非天然アミノ酸の遺伝的組込み |
CA2683960A1 (en) * | 2007-04-13 | 2008-10-23 | The Salk Institute For Biological Studies | Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal trna/synthetase pairs |
CA2707840A1 (en) * | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
AU2008316796A1 (en) | 2007-10-25 | 2009-04-30 | Massachusetts Institute Of Technology | Genetic incorporation of 3-aminotyrosine into reductases |
US20090148887A1 (en) * | 2007-11-02 | 2009-06-11 | The Scripps Research Institute | Genetically encoded boronate amino acid |
AU2008325239A1 (en) | 2007-11-02 | 2009-05-14 | The Scripps Research Institute | Directed evolution using proteins comprising unnatural amino acids |
WO2009075788A1 (en) * | 2007-12-05 | 2009-06-18 | Semprus Biociences Corporation | Synthetic non-fouling amino acids |
AU2008335778B2 (en) * | 2007-12-11 | 2014-04-10 | The Scripps Research Institute | In vivo unnatural amino acid expression in the methylotrophic yeast Pichia pastoris |
CA2712080A1 (en) * | 2008-02-08 | 2009-08-13 | The Scripps Research Institute | Breaking immunological tolerance with a genetically encoded unnatural amino acid |
US20090286968A1 (en) | 2008-04-25 | 2009-11-19 | Auburn University | 2-Quinoxalinol Salen Compounds and Uses Thereof |
ES2477543T3 (es) * | 2008-10-24 | 2014-07-17 | Irm Llc | Pirrolina-carboxi-lisina generada biosintéticamente y modificaciones de proteínas específicas de sitio mediante derivatización química de restos de pirrolina-carboxi-lisina y pirrolisina |
US20090197339A1 (en) * | 2008-12-10 | 2009-08-06 | The Scripps Research Institute | In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris |
CN102307905B (zh) * | 2008-12-10 | 2015-11-25 | 斯克利普斯研究院 | 利用化学反应性非天然氨基酸产生载体-肽偶联物 |
WO2010096394A2 (en) | 2009-02-17 | 2010-08-26 | Redwood Biosciences, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
US20120077224A1 (en) * | 2009-06-05 | 2012-03-29 | The Salk Institute For Biological Studies | unnatural amino acid incorporation in eukaryotic cells |
CN103108650A (zh) | 2010-08-25 | 2013-05-15 | Atyr医药公司 | 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
JP6162606B2 (ja) | 2011-01-14 | 2017-07-12 | レッドウッド バイオサイエンス, インコーポレイテッド | アルデヒド−タグ付き免疫グロブリンポリペプチド及びその使用方法 |
US9714419B2 (en) | 2011-08-09 | 2017-07-25 | Atyr Pharma, Inc. | PEGylated tyrosyl-tRNA synthetase polypeptides |
GB201201100D0 (en) * | 2012-01-20 | 2012-03-07 | Medical Res Council | Polypeptides and methods |
CN103379163B (zh) * | 2012-04-25 | 2016-04-06 | 阿里巴巴集团控股有限公司 | 一种业务对象的确定方法以及确定装置 |
IN2014DN09922A (es) | 2012-05-18 | 2015-08-14 | Medical Res Council | |
MX2014015205A (es) * | 2012-06-14 | 2015-08-14 | Ambrx Inc | Anticuerpos anti-psma conjugados a polipeptidos de ligando de receptor nuclear. |
SI3584255T1 (sl) | 2012-08-31 | 2022-05-31 | Sutro Biopharma, Inc | Modificirane aminokisline, ki vsebujejo azido skupino |
CA2936092A1 (en) | 2013-01-23 | 2014-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Stabilized hepatitis b core polypeptide |
EA201591465A1 (ru) | 2013-02-08 | 2015-12-30 | АйАрЭм ЭлЭлСи | Специфичные участки для модификации антител для получения иммуноконъюгатов |
WO2014146575A1 (en) | 2013-03-19 | 2014-09-25 | Beijing Shenogen Pharma Group Ltd. | Antibodies and methods for treating estrogen receptor-associated diseases |
CN110559435B (zh) | 2013-09-11 | 2023-10-20 | 伊戈尔生物药品股份有限公司 | 包含离子性液体的液体蛋白质制剂 |
US9834775B2 (en) | 2013-09-27 | 2017-12-05 | President And Fellows Of Harvard College | Recombinant cells and organisms having persistent nonstandard amino acid dependence and methods of making them |
CN104592364B (zh) * | 2013-10-30 | 2018-05-01 | 北京大学 | 定点突变和定点修饰的腺相关病毒、其制备方法及应用 |
GB2528227A (en) | 2014-03-14 | 2016-01-20 | Medical Res Council | Cyclopropene amino acids and methods |
US20150297680A1 (en) * | 2014-04-02 | 2015-10-22 | University Of Virginia Patent Foundation | Compositions and methods for increasing protein half-life |
AU2016349786B2 (en) * | 2015-11-03 | 2023-11-16 | Ambrx, Inc. | Anti-CD3-folate conjugates and their uses |
WO2017189432A1 (en) | 2016-04-26 | 2017-11-02 | R.P. Scherer Technologies, Llc | Antibody conjugates and methods of making and using the same |
CN107179305A (zh) * | 2017-05-22 | 2017-09-19 | 合肥师范学院 | 基于内嵌染料和dna相互作用的石房蛤毒素的检测方法 |
EP3630977B1 (en) | 2017-06-02 | 2024-02-21 | Ambrx, Inc. | Methods and compositions for promoting non-natural amino acid-containing protein production |
EP4069842A1 (en) | 2019-12-02 | 2022-10-12 | Shape Therapeutics Inc. | Therapeutic editing |
CN116925237A (zh) | 2019-12-31 | 2023-10-24 | 北京质肽生物医药科技有限公司 | Glp-1和gdf15的融合蛋白以及其缀合物 |
WO2021139744A1 (en) | 2020-01-11 | 2021-07-15 | Beijing Ql Biopharmaceutical Co., Ltd. | Conjugates of fusion proteins of glp-1 and fgf21 |
WO2021216478A1 (en) | 2020-04-22 | 2021-10-28 | Merck Sharp & Dohme Corp. | HUMAN INTERLEUKIN-2 CONJUGATES BIASED FOR THE INTERLEUKIN-2 RECEPTOR BETA GAMMAc DIMER AND CONJUGATED TO A NONPEPTIDIC, WATER-SOLUBLE POLYMER |
CA3193453A1 (en) | 2020-09-30 | 2022-04-07 | Beijing Ql Biopharmaceutical Co., Ltd. | Polypeptide conjugates and methods of uses |
CN113388654A (zh) * | 2021-06-04 | 2021-09-14 | 清华大学 | 一种基于线形模板无细胞体系非天然氨基酸嵌入方法 |
KR102655597B1 (ko) * | 2021-06-14 | 2024-04-08 | 전남대학교 산학협력단 | 티로실-tRNA 합성효소 돌연변이체 및 이를 이용한 4-아지도-L-페닐알라닌의 결합능이 향상된 단백질 생산방법 |
US20230201365A1 (en) | 2021-07-09 | 2023-06-29 | Bright Peak Therapeutics Ag | Modified cd20 antibodies and uses thereof |
EP4366778A1 (en) | 2021-07-09 | 2024-05-15 | Bright Peak Therapeutics AG | Antibody conjugates and manufacture thereof |
US20230250181A1 (en) | 2021-07-09 | 2023-08-10 | Bright Peak Therapeutics Ag | Modified checkpoint inhibitors and uses thereof |
US20230183331A1 (en) | 2021-07-09 | 2023-06-15 | Bright Peak Therapeutics Ag | Modified tnf-alpha antibodies and uses thereof |
CA3222359A1 (en) | 2021-07-09 | 2023-01-12 | Bright Peak Therapeutics Ag | Conjugates of checkpoint inhibitors with il-2, and uses thereof |
EP4370680A2 (en) | 2021-07-16 | 2024-05-22 | Aptah Bio, Inc. | Polynucleotide compositions and methods for gene expression regulation |
WO2023161854A1 (en) | 2022-02-23 | 2023-08-31 | Bright Peak Therapeutics Ag | Immune antigen specific il-18 immunocytokines and uses thereof |
US20240132563A1 (en) | 2022-02-23 | 2024-04-25 | Bright Peak Therapeutics Ag | Bifunctional cytokine compositions |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH652145A5 (de) | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
US4634666A (en) | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
US5001065A (en) | 1987-05-27 | 1991-03-19 | Cetus Corporation | Human cell line and triomas, antibodies, and transformants derived therefrom |
GB9608001D0 (en) * | 1996-04-18 | 1996-06-19 | Smithkline Beecham Plc | Novel compounds |
WO1999061654A1 (en) | 1998-05-27 | 1999-12-02 | The Scripps Research Institute | Methods and systems for predicting protein function |
JP2005502322A (ja) | 2001-04-19 | 2005-01-27 | ザ スクリップス リサーチ インスティテュート | 非天然アミノ酸のインビボ組込み |
US7074201B2 (en) | 2001-06-18 | 2006-07-11 | Amei Technologies, Inc. | Measurement device for fitting a bracing device |
WO2003014354A1 (en) | 2001-08-01 | 2003-02-20 | Japan Science And Technology Agency | Tyrosyl-trna synthase variants |
CN1379094A (zh) | 2002-02-01 | 2002-11-13 | 杭州华大基因研发中心 | 耐高温酪氨酰tRNA合成酶基因及其编码的多肽和制备方法 |
KR20050073559A (ko) | 2002-10-16 | 2005-07-14 | 더 스크립스 리서치 인스티튜트 | 당단백질 합성 |
DE60327369D1 (de) * | 2002-10-16 | 2009-06-04 | Scripps Research Inst | Stellenspezifischer einbau von ketoaminosäuren in proteine |
WO2004058946A2 (en) | 2002-12-22 | 2004-07-15 | The Scripps Research Institute | Protein arrays |
US7618775B2 (en) * | 2003-04-17 | 2009-11-17 | The Scripps Research Institute | Expanding the eukaryotic genetic code |
EP1636340A4 (en) * | 2003-06-18 | 2009-02-11 | Scripps Research Inst | COMPLEMENTS TO THE GENETIC CODE OF UNNATURATIVE REACTIVE AMINO ACIDS |
WO2005000829A1 (ja) * | 2003-06-26 | 2005-01-06 | Takeda Pharmaceutical Company Limited | カンナビノイド受容体調節剤 |
EP1704242A4 (en) * | 2003-07-07 | 2008-06-18 | Scripps Research Inst | COMPOSITIONS WITH PAIRS OF ORTHOGONAL LEUCYL-TRNA AND AMINOACYL-TRNA-SYNTHETASE AND USES THEREOF |
PT1914314E (pt) | 2003-07-07 | 2010-09-08 | Scripps Research Inst | Composições de pares ortogonais de lisil-arnt e aminoacil-arnt-sintetase e suas utilizações |
EP1658366A4 (en) * | 2003-07-07 | 2006-08-09 | Scripps Research Inst | COMPOSITIONS OF ORTHOGONAL GLUTAMYL-TRNA AND AMINOACYL-TRNA-SYNTHETASEPAARES AND THEIR USES |
JP5657850B2 (ja) | 2003-10-14 | 2015-01-21 | ザ スクリプス リサーチ インスティテュート | 酸化還元機能性アミノ酸のタンパク質への部位特異的組み入れ |
AU2004321117B2 (en) * | 2003-12-18 | 2010-09-02 | The Scripps Research Institute | Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells |
-
2004
- 2004-04-16 EP EP04785787A patent/EP1636340A4/en not_active Withdrawn
- 2004-04-16 MX MXPA05013833A patent/MXPA05013833A/es active IP Right Grant
- 2004-04-16 US US10/561,121 patent/US7993872B2/en active Active
- 2004-04-16 WO PCT/US2004/011833 patent/WO2005003294A2/en active Search and Examination
- 2004-04-16 JP JP2006517088A patent/JP5275566B2/ja not_active Expired - Lifetime
- 2004-04-16 US US10/826,919 patent/US7888063B2/en active Active
- 2004-04-16 EP EP14171211.7A patent/EP2793027B1/en not_active Expired - Lifetime
- 2004-04-16 BR BRPI0411475-2A patent/BRPI0411475A/pt not_active Application Discontinuation
- 2004-04-16 CA CA002527877A patent/CA2527877A1/en not_active Abandoned
- 2004-04-16 CN CN201210057706.2A patent/CN102618605B/zh not_active Expired - Lifetime
- 2004-04-16 ES ES14171211T patent/ES2773664T3/es not_active Expired - Lifetime
- 2004-04-16 EP EP11163742.7A patent/EP2378288B1/en not_active Expired - Lifetime
- 2004-04-16 EP EP11165139.4A patent/EP2392923B1/en not_active Expired - Lifetime
- 2004-04-16 EP EP11165160.0A patent/EP2410331B1/en not_active Expired - Lifetime
-
2011
- 2011-06-23 US US13/135,129 patent/US8445446B2/en not_active Expired - Lifetime
-
2013
- 2013-03-06 US US13/787,400 patent/US8815542B2/en not_active Expired - Lifetime
- 2013-03-06 JP JP2013044435A patent/JP5837526B2/ja not_active Expired - Lifetime
-
2014
- 2014-07-22 US US14/338,113 patent/US9797908B2/en active Active
- 2014-11-07 HK HK14111287.3A patent/HK1197602A1/xx unknown
-
2015
- 2015-08-13 JP JP2015159782A patent/JP6306545B2/ja not_active Expired - Lifetime
-
2017
- 2017-12-08 JP JP2017236111A patent/JP2018048203A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1197602A1 (en) | Unnatural reactive amino acid genetic code additions | |
IL175661A0 (en) | Glycopegylated factor ix | |
IL172403A0 (en) | D-amino acid peptides | |
GB0208331D0 (en) | Proteins | |
EP1541688A4 (en) | NOVEL PEPTIDE SYNTHESIS | |
PL1689775T3 (pl) | Białka wiążące GAG | |
GB0209884D0 (en) | Proteins | |
EP1552826A4 (en) | AMINO ACID COMPOSITIONS TO IMPROVE CENTRAL FUNCTIONS | |
AU2003295462A8 (en) | Lipid-associated proteins | |
EP1487874A4 (en) | FALP PROTEINS | |
AU2003296663A8 (en) | Endothelial cell specifically binding peptides | |
GB0212067D0 (en) | Proteins | |
ZA200706129B (en) | Glycopegylated Factor IX | |
IL169260A0 (en) | Il-8 -like proteins | |
AU2003270055A8 (en) | Neurotransmission-associated proteins | |
GB0206684D0 (en) | Novel proteins | |
AU2003271085A1 (en) | Amino acid iron complex | |
AU2003300785A8 (en) | Carbohydrate-associated proteins | |
AU2003295760A8 (en) | Organelle-associated proteins | |
GB0216757D0 (en) | Proteins | |
GB0214543D0 (en) | Proteins | |
GB0211242D0 (en) | Genetic manipulation | |
GB0229119D0 (en) | Genetic susceptibility | |
GB0209433D0 (en) | SFR2 protein encoding gene | |
GB0217894D0 (en) | Homing peptides |